Daniella Beckman

Daniella Beckman

Director/Board Member at VOR BIOPHARMA INC.

Net worth: 3 M $ as of 2026-05-30

47 year
Health Technology
Consumer Services
Finance

Profile

Daniella Beckman is Lead Independent Director at Vor Biopharma, Inc. since 2026 and Independent Director at Upstream Bio, Inc. since 2024.
Former roles include Independent Director at Blueprint Medicines Corp.
from 2021 to 2025, Independent Director at 5:01 Acquisition Corp.
from 2020 to 2022, Independent Director at Translate Bio, Inc. from 2017 to 2021, Chief Financial Officer & PAO at Tango Therapeutics, Inc. from 2016 to 2026, Chief Financial Officer at BioNTech US, Inc. from 2015 to 2019, Chief Financial Officer at Beckman Consulting LLC from 2015 to 2019, CFO, Treasurer, Director & Vice President at Idenix Pharmaceuticals LLC from 2011 to 2014.
Education includes undergraduate studies at Boston University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-31 131,689 ( 0.09% ) 3 M $ 2026-05-30
2026-06-08 0 ( -.--% ) - $ 2026-05-30
2026-06-10 0 ( -.--% ) - $ 2026-05-30

Daniella Beckman active positions

CompaniesPositionStart
VOR BIOPHARMA INC. Director/Board Member 2020-07-15
UPSTREAM BIO, INC. Director/Board Member 2024-10-10

Former positions of Daniella Beckman

CompaniesPositionEnd
TANGO THERAPEUTICS, INC. Director of Finance/CFO 2026-04-14
BLUEPRINT MEDICINES CORPORATION Director/Board Member 2025-07-16
501 ACQU Director/Board Member 2021-12-31
TRANSLATE BIO, INC. Director/Board Member 2021-09-13
NEON THERAPEUTICS, INC. Director of Finance/CFO 2019-08-31
See the detail of Daniella Beckman's experience

Training of Daniella Beckman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

48

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Daniella Beckman